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a feasible alternative in high-volume center?Although various appliances were introduced to facilitate surgi-
cal treatment of bladder outlet obstruction due to benign prostatic
hyperplasia,1 open simple prostatectomy (OSP) has never been
abandoned for a century.2 For large volume prostatic enlargement
(> 80mL), OSP is still recognized as a standardmethod by American
urological association (AUA) and European association of urology
(EAU) guidelines.3,4 In recent 2e3 decades, there have been
continual efforts on minimally invasive simple prostatectomy
(MISP), laparoscopic simple prostatectomy (LSP), or robot-assisted
simple prostatectomy (RASP), to alleviate the comorbidities and
complications of OSP. In the latest and, to date, the largest series
of EuropeaneAmerican multi-institutional analysis of MISP, the
safety and effectiveness were conﬁrmed in various healthcare sys-
tems. The complication rate was low and most of them are low
grade. The estimated blood loss of the robotic group was signiﬁ-
cantly less than that in the laparoscopic group, but the operation
time was longer in the robotic group. Limitations of such a retro-
spective study in nature and lacking control group existed in this
study.5 In general, the blood loss and blood transfusion rate of
RASP are favorablewhen comparedwith transurethral lasermanip-
ulation, but are less favorable than those of LSP and OSP for large
volume prostatic enlargement. The operation time of RASP was
acceptable in comparisonwith OSP and Holmium laser enucleation
of prostate (HoLEP). The length of hospital stay following RASP was
obviously shorter than that following OSP, but was still longer than
that of transurethral laser or bipolar counterpart. In addition, the
catheterization time of RASP was longer than the transurethral
techniques.6,7
The feasibility, safety, and effectiveness of RASP were not in
doubt in all of the investigations. However, the trend of robotic
surgery depends on many situations; most importantly, the devel-
opment of socioeconomic status. The authors gave an important
and valuable introduction to RASP for large volume prostatic
enlargement in Asian men. With a limited case number, nothing
could be proved here. However, few studies from Asia implement-
ing MISP, especially RASP, could be discovered in the literature.
The institute where this study was carried out is one of the pio-
neers of urological robotic surgery in Taiwan, and the key author
has the highest robotic prostate surgery volume. Thus, the trans-
formation of experience from robot-assisted radical prostatectomy
into RASP is very ﬂuent and crucial. Based on the level of experi-
ence of robot-assisted radical prostatectomy, the period of the
learning curve in RASP might even be shortened. Patients canhttp://dx.doi.org/10.1016/j.urols.2016.05.006
1879-5226/Copyright © 2016, Taiwan Urological Association. Published by Elsevier Ta
creativecommons.org/licenses/by-nc-nd/4.0/).always beneﬁt from the surgery by such experts in high volume
centers.
No one can agree more with the author's opinion that RASP is
an feasible alternative for large volume prostatic enlargement
nowadays. However, will it be the golden standard in the future
when the robotic surgical system is economically friendly avail-
able? Some concerns for RASP were raised by experts in the cen-
ter with high volume HoLEP, including catheterization time,
abdominal wound (including drain), hospital stay, adequacy of
adenoma removal, learning curve phenomenon, postoperative
stress urinary incontinence, and erectile dysfunction.8 Compari-
son in further delicate study should not only be made between
LSP and RASP. The evolving transurethral laser prostatectomy
for large volume prostatic enlargement will deﬁnitely play an
important role in minimally invasive therapies. Also, the factors
inﬂuencing selection of surgical methods, such as surgeon's
experience or preference, available facilities in various clinical
practices, cost-effectiveness, and patients' comorbidities, perfor-
mance status, misgivings, and demands, should all be taken
into consideration.
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